Senior Product Manager - Prescription (x/f/m)

at  Doctolib

WHAT WE DO

Join a team of passionate entrepreneurs to transform healthcare!
Working in the product & tech team at Doctolib involves building innovative products and features to improve the daily lives of care teams and patients. We work in feature teams collaborating with engineering, design, and business teams.

We are looking for a Senior Product Manager (x/f/m) to join our teams working on the prescription module inside our clinical Software.

As a Senior Product Manager (x/f/m), your mission will be to shape a prescription module that will transform the way practitioners and patients experience this key moment of the care path. We want to radically change the way prescription is currently done by:

• Reducing the medical errors and contributing to the governments’ initiatives in terms of drug consumption reduction
• Making the process of creating prescriptions more easy than ever before (suggestions, access to information for the caregivers etc..)
• Having a holistic approach and leveraging Doctolib’s assets to improve the drug adherence.

Your responsibilities include but are not limited to:

• Understand the needs and context of key players of the prescription experience (doctors, medical assistants, pharmacists, patients) using qualitative (field trips, interviews, prototype testing…) and quantitative data across several countries and clusters
• Know and Incorporate the regulations constraints of each country to make sure we are compliant whilst remaining easy to use.
• Analyze the competitive landscape, business and technical context through benchmarking and research
• Define the vision, own the product strategy and translate them into clear and measurable objectives.
• Build a prioritized roadmap and product plan to deliver this vision in a scalable way, taking into account Doctolib’s growth plan.
• Lead the execution of the projects autonomously, from problem definition to solution framing, specs writing, validation of developments, rollout and follow-up results and impacts